The issue of reducing the backlog of the examination of patent applications has become a priority for the Brazilian PTO. In 2019, a programme aiming at expediting the examination procedure was created targeting patents applications filed until December 31 2016. This...
As mentioned in our previous post on this topic, patent applications for pharmaceutical products or processes must be submitted to ANVISA (The Brazilian Health Surveillance Agency) for prior consent based on a public health analysis. The government lists many...
Hello! We inform you that our website uses only essential cookies to enable navigation through the virtual environment and ensure the security of our systems.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.